RE:RE:RE:Good NewsIf my recollection is accurate, with each announcement of a new clinical site launch the company continues to indicate their goal of applying for Breakthrough Designation. This seems to indicate to me that the company remains confident that, not only will they reach 25 treated patients but that their clinical data to date continues to support that application. I anticipate the next set of data with hope and enthusiasm.
John